Once blamed on alcohol, the silent liver disease now tracks obesity, diabetes and modern lifestyles—and India is racing up ...

The younger, seemingly fit population is increasingly being afflicted with lean fatty liver disease due to hidden visceral ...

Between 2010 and 2021, India recorded a 13.2 percent increase in non-alcoholic fatty liver disease (NAFLD) cases. According ...

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and if it is accurately predicted ...

Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosis Noninvasive test data ...

InSphero, leader in enabling pharma researchers to use predictive, human 3D cell-based disease models expands its NASH portfolio in collaboration with VUB This licensing agreement allows us to bring ...

Mitochondrial respiratory complexes (Complexes I–V) and their assembly into respiratory supercomplexes (SCs) are fundamental to liver bioenergetics, redox homeostasis, and metabolic adaptability.

Liver disease includes any condition that damages your liver. Over time, scar tissue can build up in your liver. Scarring or fibrosis can progress over many years until you develop cirrhosis—the most ...

SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS WIRE)--Phase 2 clinical results with HTD1801, a novel orally active ionic salt of berberine and ursodeoxycholic acid, substantially reduced liver fat while ...

NORCROSS, Ga., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will ...